title: [Gammahydroxybutyrate must remain available for patients with narcolepsy].
abstract: There is growing public concern about the use of gamma-hydroxybutyrate (GHB) as a party drug. This justified concern about misuse, however, should not lead to prohibition of the drug as it is efficacious in narcolepsy.
authors.affiliation: Leids Universitair Medisch Centrum, afd. Neurologie en Klinische neurofysiologie, Leiden.
authors.forename: G J
authors.initials: GJ
authors.lastname: Lammers
authors.forename: J G
authors.initials: JG
authors.lastname: van Dijk
authors.forename: M D
authors.initials: MD
authors.lastname: Ferrari
authors.forename: J M
authors.initials: JM
authors.lastname: van Gerven
authors.forename: A C
authors.initials: AC
authors.lastname: Declerck
authors.forename: J
authors.initials: J
authors.lastname: Troost
mesh_terms: D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000627:therapeutic use*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D013287:Illicit Drugs / Q000331:legislation & jurisprudence; D009290:Narcolepsy / Q000188:drug therapy*; D009426:Netherlands; D012978:Sodium Oxybate / Q000008:administration & dosage / Q000627:therapeutic use*; D019966:Substance-Related Disorders / Q000517:prevention & control*
chemical_list: D000697:Central Nervous System Stimulants; D013287:Illicit Drugs; D012978:Sodium Oxybate